Skip to main content

and
  1. Article

    Open Access

    Adherence to the National Guidelines for Follow-Up Protocol in Subjects with Type 2 Diabetes Mellitus in Greece: The GLANCE Study

    Physician adherence, or lack therefore, to diabetes care and follow-up guidelines may be linked to the rates of achieving suboptimal glycaemic, blood pressure and lipid targets in people with type 2 diabetes ...

    Nikolaos Papanas, Moses Elisaf, Kalliopi Kotsa, Andreas Melidonis in Diabetes Therapy (2020)

  2. No Access

    Article

    Drug-Induced Hypophosphatemia: Current Insights

    Phosphate is actively involved in many important biochemical pathways, such as energy and nucleic acid metabolism, cellular signaling, and bone formation. Hypophosphatemia, defined as serum phosphate levels be...

    Efstathia Megapanou, Matilda Florentin, Haralampos Milionis, Moses Elisaf in Drug Safety (2020)

  3. Article

    Open Access

    Influence of Supervised Disease Understanding and Diabetes Self-Management on Adherence to Oral Glucose-Lowering Treatment in Patients with Type 2 Diabetes

    Systematic patient education has been reported to improve adherence to treatment, leading to better clinical outcomes. This cluster randomized real-world study investigated the effect of a systematic education...

    John Doupis, Theodoros Alexandrides, Moses Elisaf, Andreas Melidonis in Diabetes Therapy (2019)

  4. No Access

    Article

    Lipid testing in infectious diseases: possible role in diagnosis and prognosis

    Acute infections lead to significant alterations in metabolic regulation including lipids and lipoproteins, which play a central role in the host immune response. In this regard, several studies have investiga...

    Sebastian Filippas-Ntekouan, Evangelos Liberopoulos, Moses Elisaf in Infection (2017)

  5. No Access

    Article

    Expert consensus on the rational clinical use of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors

    Two proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, evolocumab and alirocumab, have recently been approved by both the Food and Drug Administration (FDA) and the European Medicines Agency (EM...

    Apostolos Achimastos, Theodoras Alexandrides, Dimitrios Alexopoulos in Hormones (2016)

  6. No Access

    Article

    Crescentic glomerulonephritis and membranous nephropathy: a rare coexistence

    The coexistence of crescents and membranous glomerulonephritis (MGN) is a special characteristic in lupus nephritis. In the absence of the characteristic histological features of lupus nephritis, MGN with cres...

    Olga Balafa, Rigas Kalaitzidis, Georgios Liapis in International Urology and Nephrology (2015)

  7. No Access

    Article

    Lack of Association of the P450 Oxidoreductase *28 Single Nucleotide Polymorphism with the Lipid-Lowering Effect of Statins in Hypercholesterolemic Patients

    Inter-individual variability exists in the statin (HMG-CoA reductase inhibitor) lipid-lowering response, which is partially attributed to genetic factors. The polymorphic enzyme P450 oxidoreductase (POR) trans...

    Georgia Ragia, Vana Kolovou, Anna Tavridou, Laure Elens in Molecular Diagnosis & Therapy (2014)

  8. No Access

    Article

    Endothelial Dysfunction, But Not Structural Atherosclerosis, Is Evident Early in Children With Heterozygous Familial Hypercholesterolemia

    Children with heterozygous familial hypercholesterolemia (heFH) are prone to premature atherosclerosis. Vascular endothelial dysfunction may predict increased cardiovascular risk in children with heFH. The aim...

    Antonios P. Vlahos, Katerina K. Naka, Aris Bechlioulis in Pediatric Cardiology (2014)

  9. No Access

    Article

    Lipid-Modulating Treatments for Mixed Dyslipidemia Increase HDL-Associated Phospholipase A2 Activity with Differential Effects on HDL Subfractions

    The effect of lipid-modulating treatments on modification of high density lipoprotein (HDL) subfractions remains unknown. In this study, mixed dyslipidemia patients (n = 100) inadequately controlled with a standa...

    Anastazia Kei, Evangelos Liberopoulos, Costantinos Tellis, Moses Elisaf in Lipids (2013)

  10. Article

    Open Access

    Study rationale and design of OPTIMISE, a randomised controlled trial on the effect of benchmarking on quality of care in type 2 diabetes mellitus

    To investigate the effect of physician- and patient-specific feedback with benchmarking on the quality of care in adults with type 2 diabetes mellitus (T2DM).

    Frank Nobels, Noëmi Debacker, Carlos Brotons, Moses Elisaf in Cardiovascular Diabetology (2011)

  11. Article

    Open Access

    Native valve endocarditis due to Micrococcus luteus: a case report and review of the literature

    Micrococcus luteus endocarditis is a rare case of infective endocarditis. A total of 17 cases of infective endocarditis due to M luteus have been reported in the literature to date, all involving prosthetic valv...

    George Miltiadous, Moses Elisaf in Journal of Medical Case Reports (2011)

  12. No Access

    Article

    Ezetimibe Treatment Lowers Indicators of Oxidative Stress in Hypercholesterolemic Subjects with High Oxidative Stress

    Ezetimibe effectively reduces low-density lipoprotein cholesterol (LDL-C). In this study, we tested the hypothesis that ezetimibe monotherapy may also decrease markers of oxidative stress in subjects with hype...

    Michael S. Kostapanos, Athanasia T. Spyrou, Constantinos C. Tellis, Irene F. Gazi in Lipids (2011)

  13. No Access

    Article

    Pharmacologically-Induced Metabolic Acidosis

    Metabolic acidosis may occasionally develop in the course of treatment with drugs used in everyday clinical practice, as well as with the exposure to certain chemicals. Drug-induced metabolic acidosis, althoug...

    George Liamis, Dr Haralampos J. Milionis, Moses Elisaf in Drug Safety (2010)

  14. No Access

    Article

    A review of drug-induced hypocalcemia

    Hypocalcemia (defined as total serum calcium lower than 8.5 mg/dl or as ionized serum calcium lower than 4.7 mg/dl) is a relatively common metabolic abnormality observed in hospitalized patients. Although it i...

    George Liamis, Haralampos J. Milionis in Journal of Bone and Mineral Metabolism (2009)

  15. No Access

    Article

    Diverging trends in cardiovascular morbidity and mortality in a low risk population

    Cardiovascular (CVD) disease morbidity and mortality are changing over the years, following changes in socioeconomic conditions and underlying risk factors. However, the trends of these changes differ among va...

    Theodore Chimonas, Irene Fanouraki in European Journal of Epidemiology (2009)

  16. No Access

    Article

    Plasma Lipoproteins and Triacylglycerol are Predictors of Small, Dense LDL Particles

    Recently published data suggest that the assessment of LDL subfraction profiles may contribute to the determination of the cardiovascular risk. In this study, we tested the ability of various metabolic paramet...

    Vasilis Tsimihodimos, Irene Gazi, Christina Kostara, Alexandros D. Tselepis in Lipids (2007)

  17. No Access

    Article

    The hypertriglyceridemic waist phenotype is a predictor of elevated levels of small, dense LDL cholesterol

    The hypertriglyceridemic waist (HTGW) phenotype (hypertriglyceridemia and increased waist circumference) has been proposed as an inexpensive tool to monitor individuals with the atherogenic metabolic triad, hy...

    Irene F. Gazi, Theodosios D. Filippatos, Vasilis Tsimihodimos in Lipids (2006)

  18. Article

    Open Access

    LDL cholesterol estimation in patients with the metabolic syndrome

    The Friedewald formula (LDL-F) for the estimation of low-density lipoprotein (LDL) cholesterol concentrations is the most often used formula in clinical trials and clinical practice. However, much concern has ...

    Irene Gazi, Vasilis Tsimihodimos, Theodosios D Filippatos in Lipids in Health and Disease (2006)

  19. No Access

    Article

    The value of α-amylase and isoamylase determination in chronic renal failure patients

    Hyperamylasemia is a common finding in chronic renal failure (CRF) patients. It has been suggested that the diagnosis of acute pancreatitis in these patients is confirmed when serum amylase activities are grea...

    Epameinondas V. Tsianos, Matthew A. Dardamanis in International journal of pancreatology (1994)